SCHEMBL3439424

SCHEMBL3439424

O=Cc1cccnc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29999963 1.00 — —
SCHEMBL18327727 0.77 — —
SCHEMBL7216828 0.77 — —
SCHEMBL5809339 0.77 — —
SCHEMBL29773795 0.76 TRIM24 (0.61) —
2-Chloronicotinaldehyde SCHEMBL715765 0.74 — —
SCHEMBL346904 0.74 TRIM24 (0.59) —
2-Chloronicotinaldehyde SCHEMBL29828177 0.74 — —
SCHEMBL881418 0.74 — —
SCHEMBL20070416 0.74 KDM4E (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119707612-A Preparation method of gamma-deuterated amino acid ester 浙大宁波理工学院 2025-03-28 — — CN claimed
US-12178802-B1 3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-ol as an antitumor and antimicrobial compound King Faisal University (SA) 2024-12-31 — — US claimed
US-12134622-B1 2-benzo-[3,4-b]pyridine-[b,g]indeno[1,2;3,4]fluoreno-[1,2-d]oxonine-5,11,16,21-tetraone as an antimicrobial compound King Faisal University (SA) 2024-11-05 — — US claimed
US-12129241-B1 9-(2-hydroxypyridin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound King Faisal University (SA) 2024-10-29 — — US claimed
CN-118459299-A Gamma site deuteration method of fatty amine compound 浙大宁波理工学院 2024-08-09 — — CN claimed
US-11987570-B1 10-(2-hydroxyethyl)-9-(2-hydroxypyridin-3-yl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound King Faisal University (SA) 2024-05-21 — — US claimed
CN-117969421-A Universal sensor and method for identifying absolute configuration and optical purity of beta-chiral primary amine 中国医学科学院药物研究所 2024-05-03 — — CN claimed
CN-116425647-B Preparation method of alpha-deuterated amino acid methyl ester 浙大宁波理工学院 2024-04-02 — — CN claimed
US-11945793-B1 9-(2-hydroxypyridin-3-yl)-10[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound King Faisal University (SA) 2024-04-02 — — US claimed
US-11939315-B1 Ethyl 2-[9-(2-hydroxypyridin-3-yl)-3,6-diphenyl-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound King Faisal University (SA) 2024-03-26 — — US claimed
US-20050267044-A1 Novel compounds and compositions as cathepsin S inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2005-12-01 — — US claimed
US-6900237-B2 Sulfonamide compounds as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-05-31 — — US claimed
CN-1585757-A Oligopeptides and compositions containing them as cathepsin S inhibitors AVENTIS PHARMA INC (US) 2005-02-23 — — CN claimed
CN-1553892-A Novel compounds and compositions as cathepsin inhibitors ����˹��ҩ�﹫˾ 2004-12-08 — — CN claimed
US-20040192742-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. 2004-09-30 — — US claimed
EP-1446392-A1 OLIGOPEPTIDES AND COMPOSITIONS CONTAINING THEM AS CATHEPSIN S INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-08-18 — — EP claimed
US-20030199506-A1 Novel compounds and compositions as cathepsin S inhibitors AXYS PHARMACEUTICALS INC. 2003-10-23 — — US claimed
US-20030158231-A1 Sulfonamide compounds as protease inhibitors Celera Corporation 2003-08-21 — — US claimed
WO-2003042197-A1 OLIGOPEPTIDES AND COMPOSITIONS CONTAINING THEM AS CATHEPSIN S INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-05-22 — — WO claimed
WO-2003024923-A1 SULFONAMIDE COMPOUNDS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-03-27 — — WO claimed
Send feedback